RecruitingNot ApplicableNCT05544864

Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5

Sponsor

Deutsches Herzzentrum Muenchen

Enrollment

376 participants

Start Date

Sep 28, 2022

Study Type

INTERVENTIONAL

Conditions

Coronary Artery Disease Restenoses, Coronary

Summary

The hypothesis of the study is, that there is a significant interaction in treatment effect between the OCT pattern of neointima (heterogeneous or homogeneous) and the type of percutaneous coronary intervention (drug-eluting stent or drug-coated balloon) in patients with in-stent restenosis.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Drug coated ballloon (DCB) and a medical device called Drug eluting stent (DES) for people with coronary artery disease and restenoses, coronary. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.